How have evolutions in strategies for the treatment of relapsed/refractory multiple myeloma translated into improved outcomes for patients?

Pieter Sonneveld, E de Wit, P Moreau

Research output: Contribution to journalArticleAcademicpeer-review

32 Citations (Scopus)
17 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)153-170
Number of pages18
JournalCritical Reviews in Oncology/Hematology
Volume112
DOIs
Publication statusPublished - 2017

Research programs

  • EMC OR-01

Cite this